Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

291 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy of immune checkpoint inhibitors according to programmed cell death-ligand 1 expression in patients with non-small cell lung cancer and brain metastasis: A real-world prospective observational study.
Masuda T, Tsubata Y, Hata K, Horie M, Kiura K, Kanaji N, Inoue T, Kodani M, Yanai M, Yamaguchi K, Matsumoto N, Yamasaki M, Ishikawa N, Masuda K, Takigawa N, Kuyama S, Kubota T, Nishii K, Hotta K, Hattori N. Masuda T, et al. Among authors: nishii k. Thorac Cancer. 2024 Dec;15(34):2408-2417. doi: 10.1111/1759-7714.15469. Epub 2024 Oct 16. Thorac Cancer. 2024. PMID: 39415454 Free PMC article.
Dupilumab-induced Diffuse Alveolar Hemorrhage.
Tamura T, Okano H, Koyanagi T, Umeno T, Nishii K, Kuyama S. Tamura T, et al. Among authors: nishii k. Intern Med. 2025 Jan 1;64(1):109-112. doi: 10.2169/internalmedicine.3695-24. Epub 2024 May 16. Intern Med. 2025. PMID: 38749726 Free article.
Clinical characteristics of patients treated with immune checkpoint inhibitors in EGFR-mutant non-small cell lung cancer: CS-Lung-003 prospective observational registry study.
Kuribayashi T, Ohashi K, Nishii K, Ninomiya K, Tsubata Y, Ishikawa N, Kodani M, Kanaji N, Yamasaki M, Fujitaka K, Kuyama S, Takigawa N, Fujimoto N, Kubota T, Inoue M, Fujiwara K, Harita S, Takata I, Takada K, Okawa S, Kiura K, Hotta K. Kuribayashi T, et al. Among authors: nishii k. J Cancer Res Clin Oncol. 2024 Feb 12;150(2):89. doi: 10.1007/s00432-024-05618-4. J Cancer Res Clin Oncol. 2024. PMID: 38347279 Free PMC article.
Efficacy and Safety of Re-administration of Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor (EGFR-TKI) After EGFR-TKI-Induced Interstitial Lung Disease (CS-Lung-005).
Kanaji N, Ichihara E, Tanaka T, Ninomiya T, Kozuki T, Ishikawa N, Nishii K, Shoda H, Yamaguchi K, Kawakado K, Toyoda Y, Inoue M, Miyatake N, Watanabe N, Inoue T, Mizoguchi H, Komori Y, Kojima K, Kadowaki N. Kanaji N, et al. Among authors: nishii k. Lung. 2024 Feb;202(1):63-72. doi: 10.1007/s00408-023-00669-9. Epub 2024 Jan 24. Lung. 2024. PMID: 38265672 Free PMC article.
291 results